Breaking News Instant updates and real-time market news.

PSTV

Plus Therapeutics

$2.13 /

-0.01 (-0.47%)

07:35
12/01/20
12/01
07:35
12/01/20
07:35

Plus Therapeutics expands ReSPECT trial to MD Anderson Cancer Center

Plus Therapeutics announced that the University of Texas MD Anderson Cancer Center is now an active clinical trial site in its ongoing ReSPECT Phase 1 clinical trial, currently supported by the National Cancer Institute. ReSPECT is a multi-center, dose-finding study evaluating the Company's lead investigational asset, Rhenium NanoLiposome, in patients with recurrent glioblastoma. The study will be conducted by MD Anderson's Department of Neurosurgery with Jeffrey Weinberg, M.D., Professor of Neurosurgery and the Deputy Chair and Vice-Chair of Clinical Operations in The Department of Neurosurgery, as primary investigator. As the Company previously disclosed, the sixth dose escalation cohort of the ReSPECT trial is underway and expected to enroll by the end of 2020. In September 2020, the U.S. Food and Drug Administration granted both Orphan Drug designation and Fast Track designation to RNL for the treatment of patients with glioblastoma.

PSTV Plus Therapeutics
$2.13 /

-0.01 (-0.47%)

10/16/20
Fly Intel: Top five analyst initiations
10/16/20 Maxim
Plus Therapeutics initiated with a Buy at Maxim

TODAY'S FREE FLY STORIES

Upgrade
Morgan Stanley upgrades Gilead to Overweight at start of 'pivotal pipeline year' » 07:35
01/19/21
01/19
07:35
01/19/21
07:35
GILD

Gilead

$63.35 /

+0.95 (+1.52%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

06:01 Today Morgan Stanley
Gilead upgraded to Overweight from Equal Weight at Morgan Stanley
01/11/21 Piper Sandler
Piper says hard for Gilead investors to ascribe long-term value to Veklury
01/04/21 Guggenheim
Gilead upgraded to Buy from Neutral at Guggenheim
12/22/20 Citi
Gilead price target lowered to $72 from $75 at Citi
GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

Options
Unusual call flow in option market yesterday » 07:35
01/19/21
01/19
07:35
01/19/21
07:35
SLQT

SelectQuote

$23.55 /

+0.98 (+4.34%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/08/20 Credit Suisse
SelectQuote price target lowered to $31 from $38 at Credit Suisse
07/01/20 SVB Leerink
SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

  • 21
    May
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

Recommendations
AMN Healthcare price target raised to $81 from $72 at BMO Capital » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
AMN

AMN Healthcare

$72.10 /

+0.075 (+0.10%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
AMN AMN Healthcare
$72.10 /

+0.075 (+0.10%)

11/06/20 Truist
AMN Healthcare price target raised to $78 from $68 at Truist
11/06/20 Credit Suisse
AMN Healthcare price target raised to $76 from $63 at Credit Suisse
10/08/20 BofA
AMN Healthcare initiated with a Buy at BofA
08/07/20 BMO Capital
AMN Healthcare price target raised to $65 from $50 at BMO Capital
AMN AMN Healthcare
$72.10 /

+0.075 (+0.10%)

Earnings
Kforce expects EPS to exceed 78c per share, consensus 75c » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
KFRC

Kforce

$42.70 /

-1.28 (-2.91%)

Sees revenue exceeding…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KFRC Kforce
$42.70 /

-1.28 (-2.91%)

01/04/21 Sidoti
Kforce upgraded to Buy from Neutral at Sidoti
08/11/20 Truist
Kforce price target raised to $35 from $30 at Truist
08/11/20 William Blair
Kforce upgraded to Outperform from Market Perform at William Blair
05/28/20 Sidoti
Kforce downgraded to Neutral from Buy at Sidoti
KFRC Kforce
$42.70 /

-1.28 (-2.91%)

KFRC Kforce
$42.70 /

-1.28 (-2.91%)

Hot Stocks
Pembina Pipeline announces binding open season » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
PBA

Pembina Pipeline

$27.39 /

-0.5 (-1.79%)

Pembina Pipeline…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBA Pembina Pipeline
$27.39 /

-0.5 (-1.79%)

PBA Pembina Pipeline
$27.39 /

-0.5 (-1.79%)

01/13/21 CIBC
Pembina Pipeline price target raised to C$40 from C$38 at CIBC
12/15/20 BMO Capital
Pembina Pipeline downgraded to Market Perform from Outperform at BMO Capital
11/30/20 Wells Fargo
Pembina Pipeline downgraded to Equal Weight from Overweight at Wells Fargo
11/19/20 Canaccord
Pembina Pipeline price target lowered to C$40 from C$42 at Canaccord
Hot Stocks
Veritone, Base Media Cloud announce six-year agreement » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
VERI

Veritone

$38.75 /

-1.99 (-4.88%)

Veritone with Base Media…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERI Veritone
$38.75 /

-1.99 (-4.88%)

VERI Veritone
$38.75 /

-1.99 (-4.88%)

12/21/20 Roth Capital
Veritone price target raised to $31 from $20 at Roth Capital
12/21/20 Stifel
Veritone initiated with a Hold at Stifel
11/19/20 Roth Capital
Veritone price target raised to $20 from $18 at Roth Capital
10/06/20 Roth Capital
Veritone energy suite adds to platform's use cases, says Roth Capital
VERI Veritone
$38.75 /

-1.99 (-4.88%)

  • 03
    Dec
VERI Veritone
$38.75 /

-1.99 (-4.88%)

VERI Veritone
$38.75 /

-1.99 (-4.88%)

Initiation
Skillz platform accelerates, Canacord initiates with Buy » 07:33
01/19/21
01/19
07:33
01/19/21
07:33
SKLZ

Skillz

$24.81 /

-1.23 (-4.72%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKLZ Skillz
$24.81 /

-1.23 (-4.72%)

06:37 Today Canaccord
Skillz initiated with a Buy at Canaccord
01/15/21
Fly Intel: Top five analyst initiations
01/15/21 Wells Fargo
Skillz initiated with an Equal Weight at Wells Fargo
01/12/21 Wedbush
Skillz initiated with an Outperform at Wedbush
Hot Stocks
Accuray reports data from phase II trial using TomoTherapy System » 07:32
01/19/21
01/19
07:32
01/19/21
07:32
ARAY

Accuray

$4.76 /

-0.2 (-4.03%)

Accuray announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARAY Accuray
$4.76 /

-0.2 (-4.03%)

ARAY Accuray
$4.76 /

-0.2 (-4.03%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
09/28/20 Lake Street
CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street
09/18/20 Cowen
New CMS model should provide tailwind for Accuray, says Cowen
ARAY Accuray
$4.76 /

-0.2 (-4.03%)

ARAY Accuray
$4.76 /

-0.2 (-4.03%)

Earnings
FMC Corporation cuts Q4 revenue view to about $1.15B from $1.23B-$1.29B » 07:32
01/19/21
01/19
07:32
01/19/21
07:32
FMC

FMC Corporation

$120.03 /

-1.69 (-1.39%)

Q4 consensus $1.26B. FMC…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMC FMC Corporation
$120.03 /

-1.69 (-1.39%)

FMC FMC Corporation
$120.03 /

-1.69 (-1.39%)

11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
FMC Corporation initiated with a Market Perform at Bernstein
11/18/20 BMO Capital
FMC Corporation price target raised to $124 from $120 at BMO Capital
11/18/20 KeyBanc
FMC Corporation price target raised to $137 from $121 at KeyBanc
FMC FMC Corporation
$120.03 /

-1.69 (-1.39%)

Recommendations
Snap price target raised to $60 from $40 at KeyBanc » 07:31
01/19/21
01/19
07:31
01/19/21
07:31
SNAP

Snap

$50.29 /

+1.245 (+2.54%)

KeyBanc analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$50.29 /

+1.245 (+2.54%)

SNAP Snap
$50.29 /

+1.245 (+2.54%)

01/15/21
Fly Intel: Top five analyst upgrades
01/15/21 MoffettNathanson
Snap upgraded to Buy with $57 price target at MoffettNathanson
01/15/21 MoffettNathanson
Snap upgraded to Buy from Neutral at MoffettNathanson
01/12/21 Cowen
Snap price target raised to $62 from $45 at Cowen
SNAP Snap
$50.29 /

+1.245 (+2.54%)

SNAP Snap
$50.29 /

+1.245 (+2.54%)

SNAP Snap
$50.29 /

+1.245 (+2.54%)

SNAP Snap
$50.29 /

+1.245 (+2.54%)

Hot Stocks
Federal court dismisses class action lawsuit against 22nd Century » 07:31
01/19/21
01/19
07:31
01/19/21
07:31
XXII

22nd Century

$2.77 /

-0.05 (-1.77%)

22nd Century Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XXII 22nd Century
$2.77 /

-0.05 (-1.77%)

XXII 22nd Century
$2.77 /

-0.05 (-1.77%)

Recommendations
Assurant price target raised to $170 from $150 at Truist » 07:30
01/19/21
01/19
07:30
01/19/21
07:30
AIZ

Assurant

$31.00 /

+15 (+9.00%)

Truist analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIZ Assurant
$31.00 /

+15 (+9.00%)

AIZ Assurant
$31.00 /

+15 (+9.00%)

AIZ Assurant
$31.00 /

+15 (+9.00%)

Recommendations
Pinterest price target raised to $86 from $76 at KeyBanc » 07:30
01/19/21
01/19
07:30
01/19/21
07:30
PINS

Pinterest

/

+

KeyBanc analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
/

+

PINS Pinterest
/

+

01/08/21 Baird
Pinterest price target raised to $80 from $68 at Baird
01/05/21 Morgan Stanley
Pinterest price target raised to $80 from $73 at Morgan Stanley
01/05/21 Morgan Stanley
Facebook price target raised to $340 from $315 at Morgan Stanley
12/17/20
Fly Intel: Top five analyst initiations
PINS Pinterest
/

+

PINS Pinterest
/

+

PINS Pinterest
/

+

PINS Pinterest
/

+

Downgrade
Restaurant Brands downgraded to Equal Weight from Overweight at Morgan Stanley » 07:30
01/19/21
01/19
07:30
01/19/21
07:30
QSR

Restaurant Brands

$62.80 /

-1.41 (-2.20%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QSR Restaurant Brands
$62.80 /

-1.41 (-2.20%)

QSR Restaurant Brands
$62.80 /

-1.41 (-2.20%)

05:18 Today Goldman Sachs
Restaurant Brands initiated with a Sell at Goldman Sachs
01/15/21 BMO Capital
Restaurant Brands price target raised to $70 from $65 at BMO Capital
01/12/21 Baird
Baird cautious Restaurant Brands ahead of results
01/07/21 Stephens
Restaurant Brands upgraded to Overweight on rotation expectations at Stephens
QSR Restaurant Brands
$62.80 /

-1.41 (-2.20%)

QSR Restaurant Brands
$62.80 /

-1.41 (-2.20%)

QSR Restaurant Brands
$62.80 /

-1.41 (-2.20%)

Hot Stocks
Helius Medical regains compliance with Nasdaq listing standards » 07:30
01/19/21
01/19
07:30
01/19/21
07:30
HSDT

Helius Medical

$15.39 /

-0.36 (-2.29%)

Helius Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HSDT Helius Medical
$15.39 /

-0.36 (-2.29%)

HSDT Helius Medical
$15.39 /

-0.36 (-2.29%)

Hot Stocks
Goldman Sachs committed to medium-, long-term targets » 07:29
01/19/21
01/19
07:29
01/19/21
07:29
GS

Goldman Sachs

$301.05 /

-6.95 (-2.26%)

Medium-term targets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

01/12/21 JMP Securities
Goldman Sachs price target raised to $320 from $285 at JMP Securities
01/11/21 Piper Sandler
Goldman Sachs price target raised to $325 from $270 at Piper Sandler
01/06/21 Deutsche Bank
Goldman Sachs price target raised to $290 from $230 at Deutsche Bank
01/05/21 Wells Fargo
Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo
GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

Hot Stocks
Clene Nanomedicine receives notice of allowance for use of gold nanocrystals » 07:28
01/19/21
01/19
07:28
01/19/21
07:28
CLNN

Clene Nanomedicine

$6.60 /

-0.3 (-4.35%)

Clene announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Recommendations
Nevro price target raised to $203 from $167 at Canaccord » 07:28
01/19/21
01/19
07:28
01/19/21
07:28
NVRO

Nevro

$175.11 /

-0.555 (-0.32%)

Canaccord raised the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

NVRO Nevro
$175.11 /

-0.555 (-0.32%)

01/06/21 Truist
Nevro price target raised to $205 from $175 at Truist
01/05/21 Baird
Nevro price target raised to $200 from $180 at Baird
01/04/21 Wells Fargo
Nevro price target raised to $215 from $177 at Wells Fargo
12/31/20 Guggenheim
Nevro price target raised to $205 from $190 at Guggenheim
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

  • 02
    Apr
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

Hot Stocks
Goldman Sachs CEO: 2020 a 'challenging year on many fronts' » 07:28
01/19/21
01/19
07:28
01/19/21
07:28
GS

Goldman Sachs

$38.00 /

+20 (+7.00%)

Chairman and CEO David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$38.00 /

+20 (+7.00%)

GS Goldman Sachs
$38.00 /

+20 (+7.00%)

01/12/21 JMP Securities
Goldman Sachs price target raised to $320 from $285 at JMP Securities
01/11/21 Piper Sandler
Goldman Sachs price target raised to $325 from $270 at Piper Sandler
01/06/21 Deutsche Bank
Goldman Sachs price target raised to $290 from $230 at Deutsche Bank
01/05/21 Wells Fargo
Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo
GS Goldman Sachs
$38.00 /

+20 (+7.00%)

GS Goldman Sachs
$38.00 /

+20 (+7.00%)

GS Goldman Sachs
$38.00 /

+20 (+7.00%)

GS Goldman Sachs
$38.00 /

+20 (+7.00%)

Recommendations
Facebook price target raised to $345 from $340 at KeyBanc » 07:28
01/19/21
01/19
07:28
01/19/21
07:28
FB

Facebook

$251.42 /

+5.6 (+2.28%)

, TWTR

Twitter

$45.18 /

-0.62 (-1.35%)

KeyBanc analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$251.42 /

+5.6 (+2.28%)

TWTR Twitter
$45.18 /

-0.62 (-1.35%)

FB Facebook
$251.42 /

+5.6 (+2.28%)

05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
01/15/21 MoffettNathanson
Facebook price target raised to $325 from $285 at MoffettNathanson
01/12/21 Cowen
Facebook price target raised to $340 from $330 at Cowen
01/11/21 Cowen
Twilio powers new user verification for popular Signal app, says Cowen
TWTR Twitter
$45.18 /

-0.62 (-1.35%)

01/13/21
Fly Intel: Top five analyst upgrades
01/13/21 MKM Partners
Twitter upgraded to Buy from Neutral at MKM Partners
01/13/21 MKM Partners
Twitter upgraded to Buy from Neutral at MKM Partners
01/12/21 Wells Fargo
Wells cuts Twitter target to $43, says Trump 'will not be easily replaced'
FB Facebook
$251.42 /

+5.6 (+2.28%)

TWTR Twitter
$45.18 /

-0.62 (-1.35%)

FB Facebook
$251.42 /

+5.6 (+2.28%)

TWTR Twitter
$45.18 /

-0.62 (-1.35%)

FB Facebook
$251.42 /

+5.6 (+2.28%)

TWTR Twitter
$45.18 /

-0.62 (-1.35%)

FB Facebook
$251.42 /

+5.6 (+2.28%)

TWTR Twitter
$45.18 /

-0.62 (-1.35%)

Hot Stocks
Goldman Sachs reports Q4 ROE 21.1%, ROTE 22.5% » 07:27
01/19/21
01/19
07:27
01/19/21
07:27
GS

Goldman Sachs

$301.05 /

-6.95 (-2.26%)

Reports Q4 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

01/12/21 JMP Securities
Goldman Sachs price target raised to $320 from $285 at JMP Securities
01/11/21 Piper Sandler
Goldman Sachs price target raised to $325 from $270 at Piper Sandler
01/06/21 Deutsche Bank
Goldman Sachs price target raised to $290 from $230 at Deutsche Bank
01/05/21 Wells Fargo
Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo
GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

Hot Stocks
Climb Channel Solutions partners with ChannelOnline » 07:27
01/19/21
01/19
07:27
01/19/21
07:27
WSTG

Wayside Technology

$19.29 /

+0.53 (+2.83%)

Climb Channel Solutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSTG Wayside Technology
$19.29 /

+0.53 (+2.83%)

Upgrade
Morgan Stanley upgrades Darden to Overweight on potential for dining out surge » 07:26
01/19/21
01/19
07:26
01/19/21
07:26
DRI

Darden

$121.10 /

-2 (-1.62%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$121.10 /

-2 (-1.62%)

DRI Darden
$121.10 /

-2 (-1.62%)

06:06 Today Morgan Stanley
Darden upgraded to Overweight from Equal Weight at Morgan Stanley
05:21 Today Goldman Sachs
Darden initiated with a Buy at Goldman Sachs
12/23/20 Argus
Darden price target raised to $130 from $115 at Argus
12/21/20 KeyBanc
Darden price target raised to $130 from $124 at KeyBanc
DRI Darden
$121.10 /

-2 (-1.62%)

  • 21
    Apr
DRI Darden
$121.10 /

-2 (-1.62%)

DRI Darden
$121.10 /

-2 (-1.62%)

Hot Stocks
Goldman Sachs reports Q4 trading revenue $4.27B » 07:26
01/19/21
01/19
07:26
01/19/21
07:26
GS

Goldman Sachs

$301.05 /

-6.95 (-2.26%)

Net revenues in Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

01/12/21 JMP Securities
Goldman Sachs price target raised to $320 from $285 at JMP Securities
01/11/21 Piper Sandler
Goldman Sachs price target raised to $325 from $270 at Piper Sandler
01/06/21 Deutsche Bank
Goldman Sachs price target raised to $290 from $230 at Deutsche Bank
01/05/21 Wells Fargo
Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo
GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

Recommendations
Biohaven Pharmaceutical price target lowered to $101 from $110 at Canaccord » 07:26
01/19/21
01/19
07:26
01/19/21
07:26
BHVN

Biohaven Pharmaceutical

$84.76 /

-7.065 (-7.69%)

Canaccord analyst Sumant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

06:56 Today Mizuho
Biohaven Pharmaceutical price target lowered to $93 from $100 at Mizuho
06:22 Today H.C. Wainwright
Biohaven price target lowered to $111 from $121 at H.C. Wainwright
04:54 Today Piper Sandler
Biohaven should pull back to mid-$70's on Alzheimer's miss, says Piper Sandler
12/29/20 Cantor Fitzgerald
Biohaven price target raised to $115 from $109 at Cantor Fitzgerald
BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

  • 29
    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.